A detailed history of Sg Americas Securities, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 12,813 shares of KOD stock, worth $112,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,813
Holding current value
$112,113
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$2.2 - $3.25 $28,188 - $41,642
12,813 New
12,813 $33,000
Q1 2024

May 06, 2024

SELL
$3.01 - $7.45 $19,248 - $47,642
-6,395 Reduced 36.15%
11,294 $59,000
Q4 2023

Jan 12, 2024

SELL
$1.4 - $3.24 $3,718 - $8,605
-2,656 Reduced 13.05%
17,689 $54,000
Q3 2023

Oct 13, 2023

BUY
$1.8 - $7.49 $36,621 - $152,384
20,345 New
20,345 $37,000
Q1 2023

Apr 28, 2023

BUY
$4.81 - $8.88 $31,866 - $58,830
6,625 Added 51.88%
19,394 $120,000
Q4 2022

Feb 02, 2023

SELL
$6.52 - $8.05 $218,126 - $269,312
-33,455 Reduced 72.38%
12,769 $91,000
Q3 2022

Oct 31, 2022

BUY
$7.57 - $12.5 $17,547 - $28,975
2,318 Added 5.28%
46,224 $358,000
Q2 2022

Jul 29, 2022

BUY
$5.04 - $9.48 $46,257 - $87,007
9,178 Added 26.43%
43,906 $335,000
Q1 2022

Apr 29, 2022

BUY
$7.09 - $89.45 $117,807 - $1.49 Million
16,616 Added 91.74%
34,728 $268,000
Q4 2021

Feb 07, 2022

BUY
$80.85 - $128.49 $759,828 - $1.21 Million
9,398 Added 107.85%
18,112 $1.54 Million
Q3 2021

Nov 01, 2021

SELL
$81.97 - $106.94 $85,576 - $111,645
-1,044 Reduced 10.7%
8,714 $836,000
Q2 2021

Aug 12, 2021

BUY
$77.2 - $126.54 $429,463 - $703,942
5,563 Added 132.61%
9,758 $907,000
Q1 2021

May 13, 2021

BUY
$110.45 - $164.47 $180,696 - $269,072
1,636 Added 63.93%
4,195 $476,000
Q4 2020

Feb 04, 2021

SELL
$60.78 - $154.03 $2.14 Million - $5.42 Million
-35,212 Reduced 93.22%
2,559 $376,000
Q3 2020

Nov 09, 2020

BUY
$45.05 - $59.27 $1.3 Million - $1.71 Million
28,857 Added 323.73%
37,771 $2.24 Million
Q2 2020

Jul 20, 2020

BUY
$42.74 - $66.25 $10,556 - $16,363
247 Added 2.85%
8,914 $482,000
Q1 2020

Apr 30, 2020

BUY
$38.18 - $73.95 $231,332 - $448,063
6,059 Added 232.32%
8,667 $413,000
Q4 2019

Jan 28, 2020

BUY
$13.9 - $76.65 $36,251 - $199,903
2,608 New
2,608 $188,000
Q2 2019

Jul 29, 2019

SELL
$6.2 - $12.0 $63,023 - $121,980
-10,165 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$6.43 - $9.44 $65,360 - $95,957
10,165 New
10,165 $66,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.